Analyst Ratings for Cardiome Pharma (CRME) [Neutrals]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/19/2012 | BMO Capital | N/A | Downgrade | Market Perform (N/A) |
N/A (N/A) |
0.93 (2.33) |
150.54% | Details |
| 2/7/2011 | Barclays » Updated 3/11/2011 |
N/A | Downgrade | Equalweight (N/A) |
N/A (N/A) |
6.83 (2.33) |
-65.89% | Details |
